Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A. Huls

Publicaties

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Consolidation With Second High Dose Therapy and Autologous Stem Cell Transplantation Is Associated With Improved Overall Survival in Patients With Multiple Myeloma in First Relapse

Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy

High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis

Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation

K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy

Pers/media

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen